Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous ketamine added to midazolam for post-cesarean analgesia after spinal anesthesia
IRCT20211013052753N1Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in postoperative pain comparing Ketamine + midazolam with Midazolam alone (2 arms). Primary endpoints: Pain intensity, Amount of pain medication used and 1 more. Started Nov 2021; status: completed.
02
Drugs
ketaminemidazolam
03
Conditions
postoperative pain
Beyond the preview
Go deeper on IRCT20211013052753N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20211013052753N1.